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Background
Neuropathic bladder secondary to spina bifida may result
in serious kidney damage and socially-disabling urinary
incontinence. Failure to respond to clean intermittent cath-
eterisation and anti-cholinergic medication may necessitate
bladder augmentation, a major operation with significant
risks, including the possibility of malignant transformation
of the augment.
The development of auto-augmentation (detrusorotomy or
detrusorectomy) as an alternative procedure, where the
hypertrophic detrusor muscle is split and separated from
the intact mucosa of the bladder, promised avoidance of
many of the consequences of traditional augmentation.
However, the literature remains unclear as to whether auto-
augmentation is effective in such patients, or a sub-group
thereof, or has a role in delaying the need for a more com-
plicated procedure until later in life, when the potential for
stunting of growth may be less important.
Materials and methods
The records of all children undergoing auto-augmentation
from 1996 to 2006 in a regional specialist paediatric surgi-
cal unit were analysed. Comparisons were made between
the pre- and post-operative status for the following end-
points: continence, nephropathy, and video-urodynamic
parameters (bladder capacity, maximal detrusor pressure
[MDP], and vesico-ureteric reflux [VUR]).
Results
Comparative data were available for six girls and five boys
aged between 5 and 14 (mean = 10.3) years at the time of
detrusorotomy, in two cases accompanied by colposuspen-
sion. Follow-up period was between 1.3 and 6.8 (mean =
3.5) years post-operatively. Spina bifida was the underlying
condition in all but one of the children, all of whom had
small, poorly compliant bladders with upper tract deterio-
ration and/or failed maximal medical therapy.
Five of the 11 patients had an increase in bladder capacity
(mean increase = 40%), as a function of the predicted
capacity for age. Three had an improvement in MDP (13 –
69% reduction). Two of the three patients with pre-opera-
tive VUR had resolution following surgery. None of the
four patients with no pre-operative VUR developed it post-
operatively. Four were unable to be assessed due to incom-
plete urodynamic data.
There was no deterioration on DMSA or renal ultrasound
scan in 10 patients. One patient suffered progressive renal
scarring between the two DMSA scans, but there were 20
months between the pre-operative DMSA and surgery, dur-
ing which time this scarring may have occurred. Five
patients had a subjective improvement in continence. To
our knowledge, no patient has had further surgery to date.
Conclusion
Our study suggests that auto-augmentation was beneficial
in terms of improved urodynamic parameters in five out of
eleven children, in the medium term at least, and does not
cause deterioration in VUR. However, pre- and intra-opera-
tive predictors of success remain elusive. We suggest the
continued inclusion of auto-augmentation in the surgical
armamentarium for neuropathic bladder, but continued
follow-up is required post-operatively
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